SCHEMBL3849360

SCHEMBL3849360

CN(C)S(=O)(=O)N1CCN(c2ncnc3ccc(-c4c[nH]nc4-c4ccc(F)cc4)cc23)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 15/20 0.46
CYP1A2 P05177 14/20 0.46
ALDH1A1 P00352 11/20 0.46
CYP2C19 P33261 11/20 0.46
HIF1A Q16665 9/20 0.46
TSHR P16473 8/20 0.46
LMNA P02545 8/20 0.46
MEN1 O00255 6/20 0.46
KMT2A Q03164 6/20 0.46
CYP2D6 P10635 5/20 0.46
KDM4E B2RXH2 4/20 0.46
HPGD P15428 4/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
CLK4 Q9HAZ1 11/20 0.46
USP2 O75604 5/20 0.46
MAPK1 P28482 7/20 0.44
TP53 P04637 2/20 0.44
HSD17B10 Q99714 4/20 0.43
HTT P42858 1/20 0.42
MAPT P10636 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3848419 0.85 CYP3A4 (0.63) CYP3A4CYP1A2ALDH1A1CYP2C19HIF1A
SCHEMBL3855512 0.84 KIT (0.47) CYP3A4CYP1A2ALDH1A1CYP2C19HIF1A
SCHEMBL3845114 0.82 CYP3A4 (0.52) CYP3A4CYP1A2ALDH1A1CYP2C19HIF1A
SCHEMBL3848700 0.82 CYP3A4 (0.48) CYP3A4CYP1A2ALDH1A1CYP2C19HIF1A
SCHEMBL3849819 0.80 ACHE (0.50) CYP3A4CYP1A2ALDH1A1CYP2C19HIF1A
SCHEMBL3849265 0.80 CYP3A4 (0.56) CYP3A4CYP1A2ALDH1A1CYP2C19HIF1A
SCHEMBL3849667 0.80 CYP3A4 (0.50) CYP3A4CYP1A2ALDH1A1CYP2C19HIF1A
SCHEMBL3848383 0.79 CYP1A2 (0.48) CYP3A4CYP1A2ALDH1A1CYP2C19HIF1A
SCHEMBL3848425 0.79 ENPP1 (0.52) CYP3A4CYP1A2ALDH1A1CYP2C19HIF1A
SCHEMBL3846990 0.79 ACHE (0.54) CYP3A4CYP1A2ALDH1A1CYP2C19HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed